Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation-Reference-Cited by-同舟云学术

Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation

Published:2019-09 Issue: Volume:378 Page:114606
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

He Jun,Liu Weitao,Ge Xin,Wang Gao-Chan,Desai Vilas,Wang Shaomin,Mu Wei,Bhardwaj Vikas,Seifert Erin,Liu Ling-Zhi,Bhushan Alok,Peiper Stephen C.,Jiang Bing-Hua

Funder

National Cancer Institute

National Institutes of Environmental Health Science

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference51 articles.

1. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium;Arita;Metallomics,2009

2. Estimating the high-arsenic domestic-well population in the conterminous United States;Ayotte;Environ. Sci. Technol.,2017

3. Arsenic-associated changes to the Epigenome: what are the functional consequences?;Bailey;Curr. Environ. Health Rep.,2014

4. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?;Baylin;Nat. Rev. Cancer,2006

5. Cross-talk between site-specific transcription factors and DNA methylation states;Blattler;J. Biol. Chem.,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N6-methyladenosine facilitates arsenic-induced neoplastic phenotypes of human bronchial epithelial cells by promoting miR-106b-5p maturation;Ecotoxicology and Environmental Safety;2024-09

2. Natural products as anticancer agents and enhancing their efficacy by a mechanism-based precision approach;Exploration of Drug Science;2024-07-30

3. The role of exosome-shuttled miRNAs in heavy metal-induced peripheral tissues and neuroinflammation in Alzheimer's disease;Biomedicine & Pharmacotherapy;2024-07

4. Defining high confidence targets of differential CpG methylation in response to in utero arsenic exposure and implications for cancer risk;Toxicology and Applied Pharmacology;2024-01

5. Non-coding RNA therapeutics: Towards a new candidate for arsenic-induced liver disease;Chemico-Biological Interactions;2023-09